QR Pharma develops new drugs for the treatment of Alzhimer’s disease, that have the potential to slow down or stop the progression of the disease while enhancing cognitive function.
« Back to Client Directory
www.qrpharma.com
QR Pharma
Delaware County, Life Sciences Sector, Investment Portfoliowww.qrpharma.com
